Crescent Biopharma, Inc.

CBIO

CBIOCrescent Biopharma, Inc. US flag

NASDAQ Capital Market

13.07

USD

+0.71

- -

485.47MMarket Cap

Profitability (USD)

Profitability Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -
Return on Assets (%)	- -	-111.59
Return on Capital (%)	- -	- -
Return on Invested Capital (%)	- -	- -
Gross Margin (%)	- -	100
EBITDA Margin (%)	- -	-1,406.75
Operating Margin (%)	- -	-1,407.52
Incremental Operating Margin (%)	- -	- -
Pretax Margin (%)	- -	-1,401.16
Profit Margin (%)	- -	-1,419.61
Net Income to Common Margin (%)	- -	-1,419.61
Effective Tax Rate (%)	- -	- -
Dvd Payout Ratio (%)	- -	- -
Sustainable Growth Rate (%)	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Debt	37	2
ST Debt	- -	- -
LT Debt	37	1
Total Debt/EBITDA	- -	-0.01
Net Debt/EBITDA	- -	1.4
Total Debt/EBIT	- -	-0.01
Net Debt/EBIT	- -	1.4
EBITDA to Interest Expense	- -	-69.82
EBITDA-CapEx/Interest Expense	- -	-103.19
EBIT to Interest Expense	- -	-69.85
Interest Expense	- -	2
Common Equity/Total Assets	-43.46	82.82
Long-Term Debt/Equity (%)	- -	0.6
Long-Term Debt/Capital (%)	170.35	0.59
Long-Term Debt/Total Assets (%)	105.24	0.5
Total Debt/Equity (%)	-242.15	0.81
Total Debt/Capital (%)	170.35	0.8
Total Debt/Total Assets (%)	105.24	0.68
Net Debt to Equity	-17.55	-105.01
Net Debt/Capital (%)	-21.28	2,497.56
EBITDA	- -	-153
EBITDA-CapEx	- -	-225
Operating Income (Loss)	- -	-153

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Cash Ratio	3.62	5.91
Current Ratio	3.62	6.56
Quick Ratio	3.62	6.41
CFO/Avg Current Liab	- -	-3.13
Common Equity/Total Assets	-43.46	82.82
Long-Term Debt/Equity (%)	- -	0.6
Long-Term Debt/Capital (%)	170.35	0.59
Long-Term Debt/Total Assets (%)	105.24	0.5
Total Debt/Equity (%)	-242.15	0.81
Total Debt/Capital (%)	170.35	0.8
Total Debt/Total Assets (%)	105.24	0.68
CFO/Total Liabilities	- -	-191.87
CFO/CapEx	- -	-0.98
Altman's Z-Score	5.85	3.76

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	1.2
Days Sales Outstanding	- -	302.93
Inventory Turnover	- -	- -
Days Inventory Outstanding	- -	- -
Accounts Payable Turnover	- -	- -
Accounts Payable Turnover Days	- -	- -
Cash Conversion Cycle	- -	- -
Inventory to Cash Days	- -	- -
Inventories	- -	- -
Raw Materials	- -	- -
Work In Process	- -	- -
Finished Goods	- -	- -
Other Inventory	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Market Capitalization	486	361
- Cash & Cash Equivalents	35	213
+ Preferred Equity and Hybrid Capital	- -	4
+ Minority/Non Controlling Interest	- -	- -
+ Total Debt	37	2
Enterprise Value	488	154
Total Capital	22	205
Total Debt/Capital (%)	170.35	0.8
Total Debt / EV	0.08	0.01
EV/Sales	- -	14.16
EV/EBITDA	- -	- -
EV/EBIT	- -	- -
EV/Cash Flow to Firm	- -	- -
EV/Free Cash Flow to Firm	- -	42.64
Diluted Market Cap	- -	124
Diluted Enterprise Value	3	-84
EV per Share	25.04	5.04
TTM Sales	- -	11
TTM EBITDA	- -	-153
TTM Operating Income	- -	-153
TTM Cash Flow to Firm	- -	-69
TTM Free Cash Flow to Firm	- -	4

Multiples (USD)

Valuation Multiples API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	89.05
EV/EBIT	- -	- -
Enterprise Value	488	154
Low Price	14.06	9.81
EV/Sales	- -	14.16
EV/EBITDA	- -	- -
Price/Earnings	- -	- -
Price/Earnings Average	- -	-1.24
Price/Earnings High	- -	-2.5
Price/Earnings Low	- -	-0.66
Price/Book Value	-31.37	1.81
Price/Book Value Average	-139.26	2.8
Price/Book Value High	-444.7	5.66
Price/Book Value Low	-17.71	1.5
Price/Tangible Book Value	-31.37	1.81
Price/Tangible Book Value Average	-139.26	2.8
Price/Tangible Book Value High	-444.7	5.66
Price/Tangible Book Value Low	-17.71	1.5
Price/Sales	- -	11.39
Price/Sales Average	- -	17.6
Price/Sales High	- -	35.53
Price/Sales Low	- -	9.42
Price/Cash Flow	- -	-1.73
Price/Cash Flow Average	- -	-2.67
Price/Cash Flow High	- -	-5.39
Price/Cash Flow Low	- -	-1.43
Price/Free Cash Flow Average	- -	137.6
Price/Free Cash Flow High	- -	277.8
Price/Free Cash Flow Low	- -	73.65
EV/Sales Average	- -	32.32
EV/Sales High	- -	84.75
EV/Sales Low	- -	8.4
EV/EBITDA Average	- -	-2.3
EV/EBITDA High	- -	-6.02
EV/EBITDA Low	- -	-0.6
EV/EBIT Average	- -	-2.3
EV/EBIT High	- -	-6.02
EV/EBIT Low	- -	-0.6
Last Price	24.9	11.86
High Price	353	37
Enterprise Value Average	2,158	350
Enterprise Value High	6,886	919
Enterprise Value Low	277	91

Profitability (USD)

Profitability Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -
Return on Assets (%)	- -	-111.59
Return on Capital (%)	- -	- -
Return on Invested Capital (%)	- -	- -
Gross Margin (%)	- -	100
EBITDA Margin (%)	- -	-1,406.75
Operating Margin (%)	- -	-1,407.52
Incremental Operating Margin (%)	- -	- -
Pretax Margin (%)	- -	-1,401.16
Profit Margin (%)	- -	-1,419.61
Net Income to Common Margin (%)	- -	-1,419.61
Effective Tax Rate (%)	- -	- -
Dvd Payout Ratio (%)	- -	- -
Sustainable Growth Rate (%)	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Debt	37	2
ST Debt	- -	- -
LT Debt	37	1
Total Debt/EBITDA	- -	-0.01
Net Debt/EBITDA	- -	1.4
Total Debt/EBIT	- -	-0.01
Net Debt/EBIT	- -	1.4
EBITDA to Interest Expense	- -	-69.82
EBITDA-CapEx/Interest Expense	- -	-103.19
EBIT to Interest Expense	- -	-69.85
Interest Expense	- -	2
Common Equity/Total Assets	-43.46	82.82
Long-Term Debt/Equity (%)	- -	0.6
Long-Term Debt/Capital (%)	170.35	0.59
Long-Term Debt/Total Assets (%)	105.24	0.5
Total Debt/Equity (%)	-242.15	0.81
Total Debt/Capital (%)	170.35	0.8
Total Debt/Total Assets (%)	105.24	0.68
Net Debt to Equity	-17.55	-105.01
Net Debt/Capital (%)	-21.28	2,497.56
EBITDA	- -	-153
EBITDA-CapEx	- -	-225
Operating Income (Loss)	- -	-153

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Cash Ratio	3.62	5.91
Current Ratio	3.62	6.56
Quick Ratio	3.62	6.41
CFO/Avg Current Liab	- -	-3.13
Common Equity/Total Assets	-43.46	82.82
Long-Term Debt/Equity (%)	- -	0.6
Long-Term Debt/Capital (%)	170.35	0.59
Long-Term Debt/Total Assets (%)	105.24	0.5
Total Debt/Equity (%)	-242.15	0.81
Total Debt/Capital (%)	170.35	0.8
Total Debt/Total Assets (%)	105.24	0.68
CFO/Total Liabilities	- -	-191.87
CFO/CapEx	- -	-0.98
Altman's Z-Score	5.85	3.76

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	1.2
Days Sales Outstanding	- -	302.93
Inventory Turnover	- -	- -
Days Inventory Outstanding	- -	- -
Accounts Payable Turnover	- -	- -
Accounts Payable Turnover Days	- -	- -
Cash Conversion Cycle	- -	- -
Inventory to Cash Days	- -	- -
Inventories	- -	- -
Raw Materials	- -	- -
Work In Process	- -	- -
Finished Goods	- -	- -
Other Inventory	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Market Capitalization	486	361
- Cash & Cash Equivalents	35	213
+ Preferred Equity and Hybrid Capital	- -	4
+ Minority/Non Controlling Interest	- -	- -
+ Total Debt	37	2
Enterprise Value	488	154
Total Capital	22	205
Total Debt/Capital (%)	170.35	0.8
Total Debt / EV	0.08	0.01
EV/Sales	- -	14.16
EV/EBITDA	- -	- -
EV/EBIT	- -	- -
EV/Cash Flow to Firm	- -	- -
EV/Free Cash Flow to Firm	- -	42.64
Diluted Market Cap	- -	124
Diluted Enterprise Value	3	-84
EV per Share	25.04	5.04
TTM Sales	- -	11
TTM EBITDA	- -	-153
TTM Operating Income	- -	-153
TTM Cash Flow to Firm	- -	-69
TTM Free Cash Flow to Firm	- -	4

Multiples (USD)

Valuation Multiples API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	89.05
EV/EBIT	- -	- -
Enterprise Value	488	154
Low Price	14.06	9.81
EV/Sales	- -	14.16
EV/EBITDA	- -	- -
Price/Earnings	- -	- -
Price/Earnings Average	- -	-1.24
Price/Earnings High	- -	-2.5
Price/Earnings Low	- -	-0.66
Price/Book Value	-31.37	1.81
Price/Book Value Average	-139.26	2.8
Price/Book Value High	-444.7	5.66
Price/Book Value Low	-17.71	1.5
Price/Tangible Book Value	-31.37	1.81
Price/Tangible Book Value Average	-139.26	2.8
Price/Tangible Book Value High	-444.7	5.66
Price/Tangible Book Value Low	-17.71	1.5
Price/Sales	- -	11.39
Price/Sales Average	- -	17.6
Price/Sales High	- -	35.53
Price/Sales Low	- -	9.42
Price/Cash Flow	- -	-1.73
Price/Cash Flow Average	- -	-2.67
Price/Cash Flow High	- -	-5.39
Price/Cash Flow Low	- -	-1.43
Price/Free Cash Flow Average	- -	137.6
Price/Free Cash Flow High	- -	277.8
Price/Free Cash Flow Low	- -	73.65
EV/Sales Average	- -	32.32
EV/Sales High	- -	84.75
EV/Sales Low	- -	8.4
EV/EBITDA Average	- -	-2.3
EV/EBITDA High	- -	-6.02
EV/EBITDA Low	- -	-0.6
EV/EBIT Average	- -	-2.3
EV/EBIT High	- -	-6.02
EV/EBIT Low	- -	-0.6
Last Price	24.9	11.86
High Price	353	37
Enterprise Value Average	2,158	350
Enterprise Value High	6,886	919
Enterprise Value Low	277	91

Shares Outstanding	20	30
Diluted Weighted Avg Shares	- -	10
Basic Weighted Avg Shares	- -	10
Revenue per Share	- -	1.04
EBITDA per Share	- -	-14.65
Operating Income per Share	- -	-14.66
Basic EPS, GAAP	- -	-14.78
Basic EPS from Cont Ops	- -	-14.78
Diluted EPS, GAAP	- -	-14.78
Diluted EPS from Cont Ops	- -	-14.78
Dividend per Share	- -	- -
Cash Flow per Share	- -	-6.87
Free Cash Flow per Basic Share	- -	-13.87
Cash & Equivalents per Share	1.78	7
Book Value per Share	-0.79	6.54
Tangible Book Value per Share	-0.79	6.54

Crescent Biopharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)